A Monte Carlo model for out-of-field dose calculation from high-energy photon therapy

Medical Physics

Volumn 34, Issue 9, 2007, Pages 3489-3499

  Kry, Stephen F ^a   Titt, Uwe ^a   Followill, David ^a   Pönisch, Falk ^b   Vassiliev, Oleg N ^a   White, R Allen ^a   Stovall, Marilyn ^a   Salehpour, Mohammad ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Dose equivalent; Monte Carlo; Neutron; Out of field; Peripheral radiation

Indexed keywords

DOSIMETRY; MONTE CARLO METHODS; NEUTRONS; PHANTOMS; PHOTONS; RADIATION EFFECTS; RADIOTHERAPY;

DOSE CALCULATION; DOSE EQUIVALENT; FIELD RADIATION; HIGH ENERGY PHOTONS; MONTE CARLO MODEL; NEUTRON FLUENCES; OUT-OF-FIELD; THERMOLUMINESCENT DOSIMETERS;

NEUTRON IRRADIATION;

ARTICLE; ELECTRON ACCELERATOR; ENERGY; MONTE CARLO METHOD; NEUTRON; PHOTON; PHOTON THERAPY; PRIORITY JOURNAL; SPECTRUM;

EID: 34548297608     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.2756940     Document Type: Article

References (50)

1. K. R. Kase, G. K. Svensson, A. B. Wolbarst, and M. A. Marks, " Measurements of dose from secondary radiation outside a treatment field., " Int. J. Radiat. Oncol. Biol. Phys. 9, 1177-1183 (1983). 0360-3016
2. R. Nath, A. Boyer, P. D. LaRiviere, R. C. McCall, and K. W. Price, AAPM Report No. 19: Neutron Measurements Around High Energy X-Ray Radiotherapy Machines. A Report of Task Group 27, Radiation Therapy Committee, American Association of Physicists in Medicine (AAPM, New York, 1986).
3. National Council on Radiation Protection and Measurements, Neutron Contamination from Medical Electron Accelerators, NCRP Report 79 (National Council on Radiation Protection and Measurements, Bethesda, Maryland, 1984).
4. National Council on Radiation Protection and Measurements, The Relative Biological Effectiveness of Rradiations of Different Quality, NCRP Report 104 (National Council on Radiation Protection and Measurements, Bethesda, Maryland, 1990).
5. E. J. Hall, S. G. Martin, H. Amols, and T. K. Hei, " Photoneutrons from medical linear accelerators: Radiobiological measurements and risk estimates., " Int. J. Radiat. Oncol. Biol. Phys. 33, 225-230 (1995). 0360-3016
6. S. F. Kry, M. Salehpour, D. Followill, M. Stovall, D. Kuban, R. White, and I. Rosen, " The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy., " Int. J. Radiat. Oncol. Biol. Phys. 62, 1195-1203 (2005). 0360-3016
7. R. M. Howell, N. E. Hertel, Z. Wang, J. Hutchinson, and G. D. Fullerton, " Calculation of effective dose from measurements of secondary neutron spectra and scattered photon dose from dynamic MLC IMRT for 6 MV, 15 MV, and 18 MV beam energies., " Med. Phys. 0094-2405 10.1118/1.2140119 33, 360-368 (2006).
8. D. J. Brenner, R. E. Curtis, E. J. Hall, and E. Ron, " Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery., " Cancer 88, 398-406 (2000). 0008-543X
9. J. D. Boice, Jr., " Second cancers following radiation treatment for cervical cancer: An international collaboration among cancer registries., " J. Natl. Cancer Inst. 74, 955-975 (1985). 0027-8874
10. E. Ron, " Cancer risks from medical radiation., " Health Phys. 0017-9078 10.1097/00004032-200307000-00011 85, 47-59 (2003).
11. C. Rubino, E. Adjadj, S. Guerin, C. Guibout, A. Shamsaldin, M. G. Dondon, D. Valteau-Couanet, O. Hartmann, M. Hawkins, and F. de Vathaire, " Long-term risk of second malignant neoplasms after neuroblastoma in childhood: role of treatment., " Int. J. Cancer 0020-7136 10.1002/ijc.11455 107, 791-796 (2003).
12. C. Rubino, F. de Vathaire, M. E. Dottorini, P. Hall, C. Schvartz, J. E. Couette, M. G. Dondon, M. T. Abbas, C. Langlois, and M. Schlumberger, " Second primary malignancies in thyroid cancer patients., " Br. J. Cancer 0007-0920 10.1038/sj.bjc.6601319 89, 1638-1644 (2003).
13. H. M. Lin and M. A. Teitell, " Second malignancy after treatment of pediatric hodgkin disease., " J. Pediatr. Hematol. Oncol. 27, 28-36 (2005). 1077-4114
14. S. Bhatia, Y. Yasui, L. L. Robison, J. M. Birch, M. K. Bogue, L. Diller, C. DeLaat, F. Fossati-Bellani, E. Morgan, O. Oberlin, G. Reaman, F. B. Ruymann, J. Tersak, and A. T. Meadows, " High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: Report from the late effects study group., " J. Clin. Oncol. 0732-183X 10.1200/JCO.2003.11.059 21, 4386-4394 (2003).
15. D. L. Preston, Y. Shimizu, D. A. Pierce, A. Suyama, and K. Mabuchi, " Studies of mortality of atomic bomb survivors, Report 13: Solid cancer and noncancer disease mortality: 1950-1997., " Radiat. Res. 0033-7587 10.1667/RR3049 160, 381-407 (2003).
16. G. Wilde and J. Sjöstrand, " A clinical study of radiation cataract formation in adult life following gamma irradiation of the lens in early childhood., " Br. J. Ophthalmol. 81, 261-266 (1997). 0007-1161
17. D. Followill, P. Geis, and A. Boyer, " Estimates of whole-body dose equivalent produced by beam intensity modulated conformal therapy., " Int. J. Radiat. Oncol. Biol. Phys. 38, 667-672 (1997). 0360-3016
18. S. Mutic and D. A. Low, " Whole-body dose from tomotherapy delivery., " Int. J. Radiat. Oncol. Biol. Phys. 42, 229-232 (1998). 0360-3016
19. D. Verellen and F. Vanhavere, " Risk assessment of radiation-induced malignancies based on whole-body dose equivalent estimates for IMRT in the head and neck region., " Radiother. Oncol. 0167-8140 10.1016/S0167-8140(99) 00079-1 53, 199-203 (1999).
20. S. F. Kry, M. Salehpour, D. Followill, M. Stovall, D. Kuban, R. A. White, and I. Rosen, " Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy., " Int. J. Radiat. Oncol. Biol. Phys. 62, 1204-1216 (2005). 0360-3016
21. R. M. Howell, M. S. Ferenci, N. E. Hertel, and G. Fullerton, " Investigation of secondary neutron dose for 18 MV dynamic MLC IMRT delivery., " Med. Phys. 0094-2405 10.1118/1.1861162 32, 786-793 (2005).
22. M. Stovall, C. R. Blackwell, J. Cundiff, D. H. Novack, J. R. Palta, L. K. Wagner, E. W. Webster, and R. J. Shalek, " Fetal dose from radiotherapy with photon beams: Report of AAPM Radiation Therapy Committee Task Group No. 36., " Med. Phys. 0094-2405 10.1118/1.597525 22, 63-82 (1995).
23. S. F. Kry, U. Titt, F. Pönisch, D. Followill, O. N. Vassiliev, R. A. White, R. Mohan, and M. Salehpour, " A Monte Carlo model for calculating out-of-field dose from a Varian 6-MV beam., " Med. Phys. 33, 4405-4413 (2006).
24. National Council on Radiation Protection and Measurements, Limitation of Exposure to Ionizing Radiation, NCRP Report 116 (National Council on Radiation Protection and Measurements, Bethesda, Maryland, 1993).
25. ICRP, ICRP Publication 60: 1990 Recommendations of the International Commission on Radiological Protection, 1990.
26. X. S. Mao, K. R. Kase, J. C. Liu, W. R. Nelson, J. H. Kleck, and S. Johnsen, " Neutron sources in the Varian Clinac 2100C/2300C medical accelerator calculated by the EGS4 code., " Health Phys. 72, 524-529 (1997). 0017-9078
27. K. R. Kase, X. S. Mao, W. R. Nelson, J. C. Liu, J. H. Kleck, and M. Elsalim, " Neutron fluence and energy spectra around the Varian Clinac 2100C/2300C medical accelerator., " Health Phys. 74, 38-47 (1998). 0017-9078
28. R. Barquero, T. M. Edwards, M. P. Iniguez, and H. R. Vega-Carrillo, " Monte Carlo simulation estimates of neutron doses to critical organs of a patient undergoing 18 MV x-ray LINAC-based radiotherapy., " Med. Phys. 0094-2405 10.1118/1.2122547 32, 3579-3588 (2005).
29. J. Lehmann, R. Stern, T. Daly, D. Rocke, C. Schwietert, G. Jones, M. Arnold, C. Siantar, and Z. Goldberg, " Dosimetry for quantitative analysis of the effects of low-dose ionizing radiation in radiation therapy patients., " Radiat. Res. 0033-7587 10.1667/RR3480.1 165, 240-247 (2006).
30. J. S. Hendricks, MCNPX, Version 2.5. e, LA-UR-04-0569, 2004.
31. F. Pönisch, U. Titt, S. F. Kry, O. N. Vassiliev, and R. Mohan, " MCNPX simulation of a multileaf collimator., " Med. Phys. 0094-2405 10.1118/1.2163833 33, 402-404 (2006).
32. P. Keall, J. Siebers, B. Libby, and R. Mohan, " Determining the incident electron fluence for Monte Carlo-based photon treatment planning using a standard measured data set., " Med. Phys. 0094-2405 10.1118/1.1561623 30, 574-582 (2003).
33. C. L. Hartmann Siantar, R. S. Walling, T. P. Daly, B. Faddegon, N. Albright, P. Bergstrom, A. F. Bielajew, C. Chuang, D. Garrett, R. K. House, D. Knapp, D. J. Wieczorek, and L. J. Verhey, " Description and dosimetric verification of the PEREGRINE Monte Carlo dose calculation system for photon beams incident on a water phantom., " Med. Phys. 0094-2405 10.1118/1.1381551 28, 1322-1337 (2001).
34. D. Sheikh-Bagheri and D. W. O. Rogers, " Sensitivity of megavoltage photon beam Monte Carlo simulations to electron beam and other parameters., " Med. Phys. 0094-2405 10.1118/1.1446109 29, 379-390 (2002).
35. G. X. Ding, " Energy spectra, angular spread, fluence profiles and dose distributions of 6 and 18 MV photon beams: Results of Monte Carlo simulations for a Varian 2100EX accelerator., " Phys. Med. Biol. 0031-9155 10.1088/0031-9155/47/7/303 47, 1025-1046 (2002).
36. S. McCormack, J. Diffey, and A. Morgan, " The effect of gantry angle on megavoltage photon beam attenuation by a carbon fiber couch insert., " Med. Phys. 0094-2405 10.1118/1.1852792 32, 483-487 (2005).
37. B. R. L. Siebert and H. Schumacher, " Quality factors, ambient, and personal dose equivalent for neutrons, based on the new ICRU stopping power data for protons and alpha particles., " Radiat. Prot. Dosimetry 58, 177-183 (1995). 0144-8420
38. H. Schumacher and B. R. L. Siebert, " Quality factors and ambient dose equivalent for neutrons based on the new ICRP recommendations., " Radiat. Prot. Dosimetry 40, 85-89 (1992). 0144-8420
39. C. P. J. Raaijmakers, M. W. Konijnenberg, H. W. Verhagen, and B. J. Mijnheer, " Determination of dose components in phantoms irradiated with an epithermal neutron beam for boron neutron capture therapy., " Med. Phys. 0094-2405 10.1118/1.597447 22, 321-329 (1995).
40. H. M. Liu, P. C. Hsu, and T. F. Liaw, " Gamma dose measurement in a water phantom irradiation with the BNCT facility at THOR., " Radiat. Prot. Dosimetry 95, 353-358 (2001). 0144-8420
41. R. Ḿndez, M. P. Iñiguez, R. Barquero, A. Mañanes, E. Gallego, A. Lorente, and M. Voytchev, " Response components of LiF:Mg, Ti around a moderated Am-Be meutron source., " Radiat. Prot. Dosimetry 98, 173-178 (2002). 0144-8420
42. T. H. Kirby, W. F. Hanson, and D. A. Johnston, " Uncertainty analysis of absorbed dose calculations from thermoluminescence dosimeters., " Med. Phys. 0094-2405 10.1118/1.596797 19, 1427-1433 (1992).
43. S. D. Davis, C. K. Ross, P. N. Mobit, L. Van der Zwan, W. J. Chase, and K. R. Shortt, " The response of LiF thermoluminescence dosemeters to photon beams in the energy range from 30 kV X-rays to 60Co gamma rays., " Radiat. Prot. Dosimetry 106, 33-43 (2003). 0144-8420
44. D. Sheikh-Bagheri and D. W. O. Rogers, " Monte Carlo calculation of nine megavoltage photon beam spectra using the BEAM code., " Med. Phys. 0094-2405 10.1118/1.1445413 29, 391-402 (2002).
45. R. Watts, " Comparative measurements on a series of accelerators by the same vendor., " Med. Phys. 0094-2405 10.1118/1.598796 26, 2581-2585 (1999).
46. S. Mutic and E. E. Klein, " A reduction in the AAPM TG-36 reported peripheral dose distributions with tertiary multileaf collimation, American Association of Physicists in Medicine Task Group 36., " Int. J. Radiat. Oncol. Biol. Phys. 44, 947-953 (1999). 0360-3016
47. R. L. Stern, " Peripheral dose from a linear accelerator equipped with multileaf collimation., " Med. Phys. 0094-2405 10.1118/1.598557 26, 559-563 (1999).
48. D. Followill, M. Stovall, S. F. Kry, and G. Ibbott, " Neutron source strength measurements for Varian, Siemens, Elekta, and General Electric linear accelerators., " J. Appl. Clin. Med. Phys. 1526-9914 10.1120/1.1571671 4, 189-194 (2003).
49. http://physics.nist.gov/cgi-bin/Star/compos.pl?matno=144
50. http://www.iec.ch/